23 November 2015 - Cumberland Pharmaceuticals announced today the launch of Caldolor in Australia. Caldolor is an intravenous formulation of ibuprofen, approved by the TGA as a new injectable, non-narcotic treatment for pain and reduction of fever in adults.

For more details, go to: http://www.prnewswire.com/news-releases/caldolor-launched-in-australia-for-treatment-of-pain-and-fever-300182946.html